GLTO logo
Damora Therapeutics, Inc.(GLTO)
$21.58Stale · unknown old
Ask SAChart

Trailing Twelve Months (TTM) Metrics

Per Share (TTM)
Revenue/Share$0.00
Net Income/Share$-4.30
Operating CF/Share$-0.69
Free CF/Share$-0.69
Cash/Share$8.84
Book Value/Share$8.44
Tangible Book/Share$8.44
Equity/Share$8.44
Interest Debt/Share$0.00
CapEx/Share$0.00
Dividend/Share$0.00
Valuation (TTM)
Market Cap$1.80B
Enterprise Value$1.25B
P/E Ratio-0.23P/S Ratio0.00
P/OCF Ratio-42.56
P/FCF Ratio-42.85
P/B Ratio3.46
P/TB Ratio3.46
EV/Sales0.00
EV/EBITDA-4.71
Graham Valuation
Graham Number--
Graham Net-Net$8.40
Profitability (TTM)
Earnings Yield-14.74%FCF Yield-2.33%ROE-82.56%ROIC-52.44%Return on Tangible Assets-48.35%
Dividend (TTM)
Dividend Yield0.00%Payout Ratio0.00%
Capital Allocation
CapEx/OCF0.00%
CapEx/Revenue0.00%
CapEx/Depreciation0.00
SBC/Revenue0.00%
SG&A/Revenue0.00%
R&D/Revenue0.00%
Liquidity & Solvency
Debt/Equity0.00Debt/Assets0.00
Debt/Market Cap0.00
Net Debt/EBITDA2.03
Current Ratio19.73Interest Coverage0.00xIncome Quality0.16
Efficiency
Days Sales Outstanding0 days
Days Payables Outstanding16088 days
Days Inventory0 days
Receivables Turnover0.00x
Payables Turnover0.02x
Inventory Turnover0.00x
Capital Structure
Tangible Assets$516.06M
Working Capital$516.04M
Invested Capital$516.04M
Intangibles/Assets0.00%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.